DocMorris AGXSWX:DOCM +0.06%65 PS Ratio is 0.24 as of Jun. 25, 2026, which is 59% below its 10-year median of 0.58. GuruFocus rates XSWX:DOCM with a GF Score™ of 65/100 and a GF Value™ of CHF10.53 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 662 Healthcare Providers & Services companies, DocMorris AG ranks better than 91.24% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, DocMorris AG's share price is CHF7.915.
DocMorris AG's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025 was CHF32.92. Hence, DocMorris AG's PS Ratio for today is 0.24.
Warning Sign:
DocMorris AG stock PS Ratio (=0.19) is close to 1-year high of 0.2.
The historical rank and industry rank for DocMorris AG's PS Ratio or its related term are showing as below:
XSWX:DOCM'
s PS Ratio Range Over the Past 10 Years
Min: 0.1 Med: 0.58 Max: 3.13
Current: 0.25
During the past 13 years, DocMorris AG's highest PS Ratio was 3.13. The lowest was 0.10. And the median was 0.58.
XSWX:DOCM's PS Ratio is ranked better than 91.24% of 662
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs XSWX:DOCM: 0.25
DocMorris AG revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of DocMorris AG was -22.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -21.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -15.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -10.90% per year.
During the past 13 years, DocMorris AG's highest 3-Year average Revenue per Share Growth Rate was 35.70% per year. The lowest was -21.60% per year. And the median was -7.55% per year.
Back to Basics: PS Ratio
DocMorris AG (XSWX:DOCM) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
DocMorris AG PS Ratio Related Terms
DocMorris AG PS Ratio Historical Data
* Premium members only.
The historical data trend for DocMorris AG's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, DocMorris AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where DocMorris AG's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
DocMorris AG's PS Ratio for today is calculated as
DocMorris AG's Share Price of today is CHF7.915.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DocMorris AG's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025 was CHF32.92.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
DocMorris AG (XSWX:DOCM) has a PS Ratio of 0.24 as of Jun. 25, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on DocMorris AG and its competitors. This is 59% below median its historical median of 0.58. Over the past decade, DocMorris AG's PS Ratio has ranged from 0.10 to 3.13. According to the industry distribution chart, DocMorris AG ranks #58 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 8.8%.
Is DocMorris AG's PS Ratio too high?
DocMorris AG's current PS Ratio of 0.24 is 59% below median its 10-year median of 0.58. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 3.13. The Healthcare Providers & Services industry median PS Ratio is 1.47. DocMorris AG's value of 0.24 is 83.7% below this industry median. Based on the distribution chart, DocMorris AG ranks #58 out of 662 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's PS Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DocMorris AG ranks #58 out of 662 companies for PS Ratio. This places DocMorris AG in the top 9% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.47. DocMorris AG's value of 0.24 is 83.7% below this benchmark. Historically, DocMorris AG's own PS Ratio has ranged from 0.10 to 3.13 over the past decade. While the company's 10-year median is 0.58 vs. the industry median of 1.47, DocMorris AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DocMorris AG's current PS Ratio of 0.24 is 83.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on DocMorris AG and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocMorris AG's current PS Ratio is 0.24, which is 59% below median its own 10-year median of 0.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF10.53, compared to a current price of CHF7.92 — trading 24.8% below its estimated fair value. The current PS Ratio is 0.24, which is 59% below median its 10-year median of 0.58 and 83.7% below the Healthcare Providers & Services industry median of 1.47. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current PS Ratio is 0.24 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF7.92 is trading 24.8% below its estimated GF Value™ of CHF10.53.
GuruFocus considers DocMorris AG to be Modestly Undervalued.
Key valuation signals for XSWX:DOCM:
PS Ratio: 0.24 (59% below median its 10-year median of 0.58)
GF Value™: CHF10.53 vs. price of CHF7.92 (24.8% below fair value)
Industry Position: 83.7% below the Healthcare Providers & Services median (#58 of 662)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 
